Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling
Abstract Activation of aldosterone/mineralocorticoid receptors (MR) has been implicated in vascular dysfunction of diabetes. Underlying mechanisms are elusive. Therefore, we investigated the role of Rho kinase (ROCK) in aldosterone/MR signaling and vascular dysfunction in a model of diabetes. Diabet...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1cbc4ec98c8b49dfb0ee07f4993edd82 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1cbc4ec98c8b49dfb0ee07f4993edd82 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1cbc4ec98c8b49dfb0ee07f4993edd822021-12-02T15:08:23ZVascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling10.1038/s41598-018-21087-52045-2322https://doaj.org/article/1cbc4ec98c8b49dfb0ee07f4993edd822018-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-21087-5https://doaj.org/toc/2045-2322Abstract Activation of aldosterone/mineralocorticoid receptors (MR) has been implicated in vascular dysfunction of diabetes. Underlying mechanisms are elusive. Therefore, we investigated the role of Rho kinase (ROCK) in aldosterone/MR signaling and vascular dysfunction in a model of diabetes. Diabetic obese mice (db/db) and control counterparts (db/+) were treated with MR antagonist (MRA, potassium canrenoate, 30 mg/kg/day, 4 weeks) or ROCK inhibitor, fasudil (30 mg/kg/day, 3 weeks). Plasma aldosterone was increased in db/db versus db/+. This was associated with enhanced vascular MR signaling. Norepinephrine (NE)-induced contraction was increased in arteries from db/db mice. These responses were attenuated in mice treated with canrenoate or fasudil. Db/db mice displayed hypertrophic remodeling and increased arterial stiffness, improved by MR blockade. Vascular calcium sensitivity was similar between depolarized arteries from db/+ and db/db. Vascular hypercontractility in db/db mice was associated with increased myosin light chain phosphorylation and reduced expression of PKG-1α. Vascular RhoA/ROCK signaling and expression of pro-inflammatory and pro-fibrotic markers were exaggerated in db/db mice, effects that were attenuated by MRA. Fasudil, but not MRA, improved vascular insulin sensitivity in db/db mice, evidenced by normalization of Irs1 phosphorylation. Our data identify novel pathways involving MR-RhoA/ROCK-PKG-1 that underlie vascular dysfunction and injury in diabetic mice.Aurelie Nguyen Dinh CatGlaucia E. CalleraMalou Friederich-PerssonAna SanchezMaria Gabriela Dulak-LisSofia TsiropoulouAugusto C. MontezanoYing HeAna M. BrionesFrederic JaisserRhian M. TouyzNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-11 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Aurelie Nguyen Dinh Cat Glaucia E. Callera Malou Friederich-Persson Ana Sanchez Maria Gabriela Dulak-Lis Sofia Tsiropoulou Augusto C. Montezano Ying He Ana M. Briones Frederic Jaisser Rhian M. Touyz Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling |
description |
Abstract Activation of aldosterone/mineralocorticoid receptors (MR) has been implicated in vascular dysfunction of diabetes. Underlying mechanisms are elusive. Therefore, we investigated the role of Rho kinase (ROCK) in aldosterone/MR signaling and vascular dysfunction in a model of diabetes. Diabetic obese mice (db/db) and control counterparts (db/+) were treated with MR antagonist (MRA, potassium canrenoate, 30 mg/kg/day, 4 weeks) or ROCK inhibitor, fasudil (30 mg/kg/day, 3 weeks). Plasma aldosterone was increased in db/db versus db/+. This was associated with enhanced vascular MR signaling. Norepinephrine (NE)-induced contraction was increased in arteries from db/db mice. These responses were attenuated in mice treated with canrenoate or fasudil. Db/db mice displayed hypertrophic remodeling and increased arterial stiffness, improved by MR blockade. Vascular calcium sensitivity was similar between depolarized arteries from db/+ and db/db. Vascular hypercontractility in db/db mice was associated with increased myosin light chain phosphorylation and reduced expression of PKG-1α. Vascular RhoA/ROCK signaling and expression of pro-inflammatory and pro-fibrotic markers were exaggerated in db/db mice, effects that were attenuated by MRA. Fasudil, but not MRA, improved vascular insulin sensitivity in db/db mice, evidenced by normalization of Irs1 phosphorylation. Our data identify novel pathways involving MR-RhoA/ROCK-PKG-1 that underlie vascular dysfunction and injury in diabetic mice. |
format |
article |
author |
Aurelie Nguyen Dinh Cat Glaucia E. Callera Malou Friederich-Persson Ana Sanchez Maria Gabriela Dulak-Lis Sofia Tsiropoulou Augusto C. Montezano Ying He Ana M. Briones Frederic Jaisser Rhian M. Touyz |
author_facet |
Aurelie Nguyen Dinh Cat Glaucia E. Callera Malou Friederich-Persson Ana Sanchez Maria Gabriela Dulak-Lis Sofia Tsiropoulou Augusto C. Montezano Ying He Ana M. Briones Frederic Jaisser Rhian M. Touyz |
author_sort |
Aurelie Nguyen Dinh Cat |
title |
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling |
title_short |
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling |
title_full |
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling |
title_fullStr |
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling |
title_full_unstemmed |
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling |
title_sort |
vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and rho kinase signaling |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/1cbc4ec98c8b49dfb0ee07f4993edd82 |
work_keys_str_mv |
AT aurelienguyendinhcat vasculardysfunctioninobesediabeticdbdbmiceinvolvestheinterplaybetweenaldosteronemineralocorticoidreceptorandrhokinasesignaling AT glauciaecallera vasculardysfunctioninobesediabeticdbdbmiceinvolvestheinterplaybetweenaldosteronemineralocorticoidreceptorandrhokinasesignaling AT maloufriederichpersson vasculardysfunctioninobesediabeticdbdbmiceinvolvestheinterplaybetweenaldosteronemineralocorticoidreceptorandrhokinasesignaling AT anasanchez vasculardysfunctioninobesediabeticdbdbmiceinvolvestheinterplaybetweenaldosteronemineralocorticoidreceptorandrhokinasesignaling AT mariagabrieladulaklis vasculardysfunctioninobesediabeticdbdbmiceinvolvestheinterplaybetweenaldosteronemineralocorticoidreceptorandrhokinasesignaling AT sofiatsiropoulou vasculardysfunctioninobesediabeticdbdbmiceinvolvestheinterplaybetweenaldosteronemineralocorticoidreceptorandrhokinasesignaling AT augustocmontezano vasculardysfunctioninobesediabeticdbdbmiceinvolvestheinterplaybetweenaldosteronemineralocorticoidreceptorandrhokinasesignaling AT yinghe vasculardysfunctioninobesediabeticdbdbmiceinvolvestheinterplaybetweenaldosteronemineralocorticoidreceptorandrhokinasesignaling AT anambriones vasculardysfunctioninobesediabeticdbdbmiceinvolvestheinterplaybetweenaldosteronemineralocorticoidreceptorandrhokinasesignaling AT fredericjaisser vasculardysfunctioninobesediabeticdbdbmiceinvolvestheinterplaybetweenaldosteronemineralocorticoidreceptorandrhokinasesignaling AT rhianmtouyz vasculardysfunctioninobesediabeticdbdbmiceinvolvestheinterplaybetweenaldosteronemineralocorticoidreceptorandrhokinasesignaling |
_version_ |
1718388108510101504 |